Love Hemp Group PLC (WRHLF)

Overview

Love Hemp Group Plc is a distinguished private equity and venture capital firm based in London, United Kingdom. Founded on January 30th, 2019, it specializes in the acquisition and investment in both early stage and mature companies. Operating on a global scale, Love Hemp Group has a keen focus on the burgeoning Cannabidiol (CBD) wellness and medicinal cannabis sectors, including hemp and its industrial applications. The firm's investment strategy is flexible, encompassing both debt and equity investments in quoted or unquoted securities through direct acquisitions, partnerships, joint ventures, licensing arrangements, or direct project interests. Love Hemp Group is particularly interested in therapeutic cannabis derivatives, cultivation of cannabis and hemp, and the broader development of CBD within the wellness sector. The firm's geographical investment footprint covers Europe, the United Kingdom, Germany, the Netherlands, North America, Australia, Japan, Thailand, Canada, Africa, South America, Israel, and Asia. It adopts a medium to long term investment horizon, though it does not shy away from shorter-term opportunities when they arise. Love Hemp Group's approach to investments varies, sometimes acquiring controlling interests or considering non-controlling positions, with a preference for taking majority stakes.

Products and Services

• Cannabidiol (CBD) Wellness and Medicinal Cannabis:

  Invests in companies developing therapeutic cannabis derivatives including nutraceuticals, dietary supplements, and cosmetic products. This also covers the investment in companies focusing on the cultivation of cannabis and hemp, emphasizing the production and distribution of premium quality CBD oils, edibles, cosmetics, capsules, and other CBD-infused products.

• Manufacture and Distribution of Medicinal Cannabis, Hemp, and CBD Products:

  Engages in the manufacturing and global distribution of medicinal cannabis, hemp, and CBD products. This includes a broad spectrum of items from pharmaceuticals to wellness products designed for both general and specific uses.

• Pharmacology and Commercialization of Medicinal Cannabis, Hemp, and CBD:

  Seeks investments in the pharmacological research, development, and commercialization of cannabis, hemp, and CBD. This encompasses support for clinical trials, laboratory testing, compliance, and the advancement of prescribing practices by professionals.

• Retail and Consumer CBD Products:

  Focused on the development and distribution of CBD products within the wellness sector, including innovative retail products like patches, topical ointments, tinctures, beverages, powdered supplements, as well as vaping products such as capsules, e-liquids, and oils. This area represents a significant part of Love Hemp Group's investment in making CBD products accessible to a wider consumer base.